Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Tata India Pharma & Healthcare Fund-Regular Plan-Growth - Portfolio Analysis

Portfolio Overview

As of October 31, 2025

Asset Allocation

Equity: 98.50%Others: 1.50%

Market Cap

Large Cap: 22.93%Mid Cap: 38.84%Small Cap: 34.36%Equity: 2.36%

Number of stocks

40

Top 10 Holdings

99.51% of portfolio

Market Cap of Equity

Large Cap
22.9338%
Mid Cap
38.8441%
Small Cap
34.3615%
Equity
2.3641%

Companies Allocation of Equity

Sun Pharmaceuticals Industries Ltd19.18%
Apollo Hospitals Enterprise Ltd10.26%
HealthCare Global Enterprises Ltd9.93%
Lupin Ltd9.81%
Max Healthcare Institute Ltd Ordinary Shares9.43%
Torrent Pharmaceuticals Ltd9.05%
Alkem Laboratories Ltd8.85%
Abbott India Ltd8.05%
Cipla Ltd7.84%
Ipca Laboratories Ltd7.11%

Sector Allocation of Equity

Healthcare96.33%
Basic Materials2.17%
Financial Services0.00%

SIP Amount

Monthly SIP Date

Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Suitabilty Test For Finding this Fund is Suitable or Not for User.Suitabilty Test For Finding this Fund is Suitable or Not for User.
Is This Mutual Fund Right for You?

+10k investors used our Suitability Test to get better returns

Frequently Asked Questions

Everything You Need To Know To Get Started With Confidence

In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.